BrightOwl Loader Loading

Experiences

Current Experience

  • Head of EMEA Bioprocess Services

    Brussels, Belgium
    Since January 2016

       Leader of 2 departments having distinct goals and business models:

    –         bioprocess development team (contract development organization - 10 people - brussels), designing, optimizing and scaling-up/industrializing processes (upstream and downstream) on behalf of customers in the field of Vaccines, Cell therapy, viral vector and oncolytic viruses production which are mostly in the early phase of Clinical Development (Preclinical to Phase III).

    –         bioprocess application specialist team (11 people located in asia, europe and us), supporting pall’s customers to transfer and industrialize their current process within single-use bioreactor platform (r&d and GMP environment). we also Coach and guide customers in their bioprocess optimization and GMP room designs.

     

    additional key roles

    –         design and challenge customer’s therapy industrialization long-term plans by combining technical and market insights while taking into account customers constraints.

    –         lifescience market trend monitoring to identify the right organizations for co-development partnerships with pall.

    –         leading collaboration with ucl (london) phd focused on cost modeling of mesenchymal and car-t Cell Manufacturing.

     

    key achievements

    –         led a 2 year viral vaccine industrialization project requiring active collaboration of several teams from 3 companies located in asia, us and europe. once the process was optimized and scaled-up by our team, it was successfully transferred to the customer Manufacturing site in asia (for Clinical Trial Phase I).

    –         our application specialist team supported >150 bioreactor platform installations with a success rate (technology adoption) >80%.  performances were such that several customers published their results (finvector, ucl, molmed…)

       Leader of 2 departments having distinct goals and business models:

    –         Bioprocess development team (Contract Development Organization - 10 people - Brussels), designing, optimizing and scaling-up/industrializing processes (Upstream and Downstream) on behalf of customers in the field of vaccines, cell therapy, viral vector and oncolytic viruses production which are mostly in the early phase of clinical development (preclinical to phase III).

    –         Bioprocess Application Specialist team (11 people located in Asia, Europe and US), Supporting Pall’s customers to transfer and industrialize their current process within single-use bioreactor platform (R&D and GMP environment). We also coach and guide customers in their bioprocess optimization and GMP room designs.

     

    Additional Key roles

    –         Design and challenge customer’s therapy industrialization long-term plans by combining technical and market insights while taking into account customers constraints.

    –         LifeScience Market trend monitoring to identify the right organizations for co-development partnerships with Pall.

    –         Leading collaboration with UCL (London) PhD focused on cost modeling of Mesenchymal and CAR-T cell manufacturing.

     

    Key Achievements

    –         Led a 2 year viral vaccine industrialization project requiring active collaboration of several teams from 3 companies located in Asia, US and Europe. Once the process was optimized and scaled-up by our team, it was successfully transferred to the customer manufacturing site in Asia (for clinical trial phase I).

    –         Our Application Specialist team supported >150 bioreactor platform installations with a success rate (technology adoption) >80%.  Performances were such that several customers published their results (Finvector, UCL, Molmed…)

Past Experience

  • Head of Cell culture Services Brussels, Belgium

    November 2014 --- December 2015

  • Senior Application Specialist - Cell Culture Lab Associate Minneapolis, MN, United States

    October 2012 --- November 2014

    context

    • given the increasing customer support demand from the us customers, atmi decided to setup a new Cell Culture department in the us
    • 2 year expatriate mission in the us – part of a team of 2 experts from brussels.

     

    key achievements

     

    additional key roles

    •  ensured visibility of collaboration project successes by presenting at conferences (bpi, isbiotech, netib), publishing posters, articles and answering interviews

  • Application Specialist

    November 2010 --- October 2012

    key achievements

    • led or contributed to the design, development, management and Sales of several single-use bioreactors (icellis®, xpansion®, padreactor®)
    • tested and successfully managed installations of alpha and beta prototypes at customer sites, leading to successful process transfers into atmi technologies.    
    • optimized and scaled-up processes (suspension and microcarrier based cultures), from 1 to 1000l scale, producing mab, influenza vaccine and mesenchymal Stem Cells.

  • Scientist

    February 2009 --- November 2010

  • Junior Scientist

    September 2008 --- February 2009

  • Intern

    July 2007 --- February 2008

    comparative study of traditional Cell Culture supports (10l glass vessel) vs disposable bioreactors (2-50l) in the context of a recombinant vaccine produced with baculovirus insect cell expression system.

  • Intern Toulouse, France

    July 2006 --- August 2006

    recombinant Protein production (e.coli) to make an enzymatic biosensor for algal toxin detection. full project, from clone screening to evaluation of enzymatic activity.

Personality

Self Assessment :
Innovative thinkingAnalytical thinkingAssertivenessCollaborationFlexibilityCuriosityEfficiencyProblem solvingProactivityTrust

Knowledge

Self Assessment :
stem cellVaccinescost modelindustrializationlab managementProject ManagementTeam coaching R&DContract negotiationGood Manufacturing Practice (GMP)Cell CultureDownstream processUpstream processBioporcess developmentViral vector
LinkedIn Assessment :
BiopharmaceuticalsVaccinesGene therapyCell TherapyStem CellsViral VectorsCell CultureBioreactordisposable bioreactorBiotechnologyGMPR&DProject ManagementPharmaceutical IndustryValidationLife Sciences

Education

  • Master's degree in Biotechnology from ENSTBB Bordeaux INP in 2008
  • in from Preparatory school - Toulouse in 2005

Languages

BrightOwl Assessment:
Self Assessment:
English
Full Proficiency
Spanish
Elementary Proficiency

Work Preferences

  • Positions I am interested in:
    Managing Director Project Coordinator R&D Senior Strategy Consultant Business Development Manager CSO COO
  • Locations I am interested in:
    Belgium France
  • Work From Home:
    No
  • Work Regime:
    Permanent position
    BrightOwl freelancer
    BrightOwl employee
  • International:
    Yes

Area / Region

Brussels, Belgium

Others

Driving License
  • No

Similar Candidates

Other Candidates in Belgium

Other Candidates in Brussels

Other similar Candidates in Brussels

Other Candidates

Most Recent Searches

Most Famous Searches

You might also like